Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review

Table 1

Patients’ characteristics.

	N = 29
Age at BMT
Median age in years (IQR)	43 (40–51)
Race
Black	5 (17%)
European American	24 (83%)
Stage at diagnosis
IIB	2 (7%)
IIIA	6 (21%)
IIIB	4 (14%)
IIIC	17 (59%)
Surgery
Lumpectomy + LN evaluation	9 (31%)
Radical mastectomy	20 (69%)
Chemotherapy
Adjuvant	25 (86%)
Neoadjuvant	4 (14%)
Positive nodes
Fewer than 4	1 (3%)
4–9	11 (38%)
10 or more	16 (55%)
Missing^∗	1 (3%)

BMT, bone marrow transplant; LN, lymph node. Number of positive nodes was determined by the surgical pathology and is the posttreatment pathological nodal stage for those that received neoadjuvant chemotherapy. ^∗This patient was staged as IIIB and received neoadjuvant therapy, which indicates the cancer was inflammatory or may have spread to the internal mammary node.